Chakraborty Arup, White Scott M, Lerner Seth P
Department of Pediatrics, Section of Leukocyte Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Urology. 2004 Jan;63(1):177-83. doi: 10.1016/s0090-4295(03)00786-6.
To examine the association of granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor (G-CSFR) expression with increased beta1-integrin expression and determine the ability of autocrine G-CSFR signaling to promote bladder cancer cell adhesion by way of beta1-integrin. beta1-integrin is expressed at higher levels in more invasive bladder carcinoma cells and participates in the process of tissue invasion. Cancer cell invasion and metastasis in some ways mimic normal neutrophil behavior. In neutrophils, G-CSF acts through its receptor to enhance adhesion and migration. A significant fraction of bladder carcinoma has been reported to express both G-CSF and G-CSFR.
We examined bladder carcinoma tissue samples obtained from segmental or radical cystectomy specimens for expression of G-CSF, G-CSFR, and beta1-integrin using reverse transcriptase-polymerase chain reaction, Western blot, and immunohistochemical methods. We determined the G-CSFR-mediated beta1-integrin adhesion using a static adhesion assay and the bladder cancer cell line 5637.
Eleven of 14 bladder cancer samples expressed G-CSFR. All 11 G-CSFR positive tumors also expressed G-CSF, and the G-CSF/G-CSFR positive tumors had elevated beta1-integrin protein levels. All but one G-CSFR negative tumor demonstrated low beta1-integrin protein levels. In four G-CSF/G-CSFR positive tumors for which distant urothelium was available for examination, G-CSF, G-CSFR, and beta1-integrin expression was also increased. In the 5637 cell line, we demonstrated G-CSFR-mediated upregulation of beta1-integrin-dependent adhesion to fibronectin and laminin.
G-CSF/G-CSFR expression in some bladder cancers appears to be an early event during malignant transformation that increases beta1-integrin expression and adhesion and thereby may promote tissue invasion.
研究粒细胞集落刺激因子(G-CSF)和G-CSF受体(G-CSFR)表达与β1整合素表达增加之间的关联,并确定自分泌G-CSFR信号通过β1整合素促进膀胱癌细胞黏附的能力。β1整合素在侵袭性更强的膀胱癌细胞中表达水平更高,并参与组织侵袭过程。癌细胞的侵袭和转移在某些方面类似于正常中性粒细胞的行为。在中性粒细胞中,G-CSF通过其受体发挥作用,增强黏附和迁移。据报道,相当一部分膀胱癌同时表达G-CSF和G-CSFR。
我们使用逆转录聚合酶链反应、蛋白质印迹法和免疫组织化学方法,检测了从部分或根治性膀胱切除标本中获取的膀胱癌组织样本中G-CSF、G-CSFR和β1整合素的表达。我们使用静态黏附试验和膀胱癌细胞系5637,测定了G-CSFR介导的β1整合素黏附情况。
14例膀胱癌样本中有11例表达G-CSFR。所有11例G-CSFR阳性肿瘤也表达G-CSF,且G-CSF/G-CSFR阳性肿瘤的β1整合素蛋白水平升高。除1例G-CSFR阴性肿瘤外,其余所有肿瘤的β1整合素蛋白水平均较低。在4例有远处尿路上皮可供检查的G-CSF/G-CSFR阳性肿瘤中,G-CSF、G-CSFR和β1整合素的表达也增加。在5637细胞系中,我们证明了G-CSFR介导的β1整合素依赖性对纤连蛋白和层粘连蛋白黏附的上调。
某些膀胱癌中G-CSF/G-CSFR的表达似乎是恶性转化过程中的早期事件,可增加β1整合素的表达和黏附,从而可能促进组织侵袭。